Healthcare Industry News: ultrasound
News Release - June 12, 2012
Toshiba’s Encore VeloCT Console Receives FDA ClearanceVeloCT Brings Latest Dose Reduction and Workflow Enhancements to Aquilion 32, 64 and CX
TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--To enable hospitals to keep pace with the latest technological advances and offer better patient care and improved workflow while containing costs, Toshiba America Medical Systems, Inc. announces the availability of VeloCT. This console upgrade includes new enhancements for patient safety, dose management and workflow for existing Aquilion™ 32, Aquilion 64 and Aquilion CX CT systems manufactured between 2006 and 2012.
The VeloCT console includes multiple dose reduction technologies and dose management tools, including:
- Adaptive Iterative Dose Reduction 3D (AIDR 3D) – This third-generation iterative dose reconstruction software incorporates significant system enhancements by helping to dramatically reduce radiation dose compared to conventional scanning. It is a sophisticated algorithm designed to work in both the raw data and image data space, reducing noise to maintain image quality.
- NEMA XR 25 Dose Check Software – Enhances user awareness of the radiation dose being administered to patients. This software includes Dose Alert and Dose Notification, addressing the two main components of MITA’s CT Dose Check Initiative.
- Tracking and Digital Imaging and Communications in Medicine (DICOM), IHE Structured Dose Report – For better dose management and more accurate reporting.
“VeloCT is an example of Toshiba’s commitment to providing customers with advanced dose management tools and workflow solutions to make CT exams even safer,” said Tim Nicholson, senior manager, Market Development, CT Business Unit, Toshiba. “VeloCT helps customers plan for the future by upgrading today’s existing technology to meet the healthcare needs of tomorrow.”
About Toshiba America Medical Systems, Inc.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
About Toshiba Medical Systems Corporation
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems; and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.1 trillion yen (US$74 billion).
Source: Toshiba America Medical Systems
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.